Answers are grounded in this paper and cite their sources.
For the next set of editorials, we will review our methods-based table of contents and comment on the various subtypes of articles included and point out some opportunities for our authors. First, we will start with our review section. Narrative Review. This may be the original type of review and should include a thorough review of the literature with the expert authors giving their priority to what is important enough to guide the narrative and conclusions for the reader. Therefore, the references may be more author selected rather than systematic. There may be a more flexible format to this subtype and opportunity for more integration of the literature with expert opinion. Our earliest issues contained such valuable reviews from the “RADAR” (Radiographic Assessment for Detection of Advanced Recurrence) group who reviewed precision imaging in advanced prostate cancer.1,2 The “RADAR VI” review1 contains clinical guidance from the panel of experts with multiple tables to summarize the when and where of advanced imaging. The “RADAR VII” review formulated useful algorithms to facilitate clinical management. As these 2 articles illustrate, narrative reviews can tackle a wide scope of topics. Depending on the scope, narrative reviews may be popular with trainees studying for certifying examinations. Authors may like these formats as opportunities to build a body of work on a particular topic. Systematic Review with/without a Meta-Analysis. These reviews follow more of a template in review methodology and have more of a mathematical approach—often with a primary aim of solving a very specific question that may otherwise remain a controversy or conflict within published studies. The meta-analysis adds review of data from multiple studies, often with the aim of increasing sample size, grouping different types of study populations, or resolving conflicting studies. A meta-analysis may or may not be possible depending on the consistency and detail of data reporting. Our first systematic review was a combined registry study with a systematic review on urinary bladder cancer incidence in patients with exstrophy/epsispadias.3 A key take-home message for authors planning such reviews is that you need to register your study similar to a trial with clinicaltrials.gov. For reviews, most authors use the PROSPERO registry. The point is to avoid duplicate efforts from other authors. Many journals will not accept non-registered reviews. As our instructions for authors cite, authors should follow the PRISMA guidelines and checklists and most articles will have thesis results as specific figures, as well as additional assessments for risk of bias from the articles included. According to the NIH, the PRISMA checklist was developed in 2009, which is a good example of how science has evolved compared with many of us who trained in the 1990s or before and were only familiar with narrative reviews. Systematic reviews require more formal training and effort, but are popular with journals, as the specific question they may answer can become a quickly citable fact for future studies (ie, they have potential to help the journal’s impact factor). Scoping Review. Somehow, I have made it through a large amount of my career without reading or learning about these reviews. I am thankful for the authorship from Patel et al4 who sent us such a review that focused on practice patterns and patient experience with prostate cancer at US Veterans hospitals. A scoping review could be either narrative or systematic in its methods. The key differentiation is that the review is more of a guidance or map of the literature, rather than an in-depth analysis. Patel et al, for example, were interested in access-to-care topics, gaps in knowledge, and health care utilization. In a way of thinking, a state-of-the-art type lecture at an educational meeting might include a scoping review. If you are asked to lecture on a topic of interest, there may be an opportunity to translate that into a publishable scoping review. Alternative Designs. At times, authors and/or journals may blur the lines between editorials, commentaries, debates (point/counterpoint), and reviews. These formats may be popular depending on the specific topic and the journal’s formats. A clinical guideline, for example, can be more narrative or systematic in its methodology. The scope of review, for example, can be very specific. We have an ongoing study in peer review that is on a very specific topic with the aim to give clinical guidance in an area not as well reviewed by full-scale clinical reviews. It may even be suitable as a “Commentary” formatted article that has limits on words, authors, and references—see our instructions for authors. February 2024 Article Reviews Reviews Punyala et al5 reported on a systematic review of saw palmetto as a treatment of prostatitis. Their primary aim was to determine safety/efficacy and compare with existing treatments including placebo results. Their search resulted in 21 studies and 1666 patients. Compared with placebo, saw palmetto improved symptoms, but had mixed results compared with alpha-blockers or 5-alpha reductase inhibitors. They made further analyses with multimodal therapy combinations with mixed results. The authors were not able to create a specific guideline or algorithm, in part, because of the inconsistency of saw palmetto formulations and lack of placebo in some studies. Trials Sugino et al6 addressed the topic of endoscopic combined intrarenal surgery for larger stones with a combined percutaneous and ureteroscopic approach. They randomized between 2 described techniques—prone vs supine—and found that 3-month stone-free rates were not different by surgical approach. The results detail some of the secondary end points around surgical time and complications depending on the exact stone location. I commend the authors for tackling this issue with a randomized design because such efforts will include prospective statistical considerations as well as IRB approvals and oversight. For such articles, we use our in-house statistical editors, and this study gave us some challenges in resolving differences of opinion. The main limitation is that a 30% difference for a noninferiority trial is quite large. Associate Editor Fernando Kim will have a forthcoming editorial on this study that should be of interest to future authors designing noninferiority trials. Bianco et al7 reported an early-phase/pilot trial evaluation of a novel transperineal method of laser ablation for benign prostatic hyperplasia under local anesthesia. In a single-arm/single-center study, 20 procedures were performed successfully under local anesthesia. They reported safety outcomes and improved symptom scores through 24 months of follow-up. This technology joins the growing list of minimally invasive options for benign prostatic hyperplasia and will have feasibility for focal therapy for prostate cancer as well. Health Services Research Kaye et al8 performed a qualitative research study designed to learn how physicians make first-line decisions in advanced prostate cancer. The key background situation is that many of the newer treatments in advanced prostate cancer lack head-to-head comparisons and have different profiles in cost and side effects. The key finding was that nonclinical factors drive a lot of decision making—see their summary figure. One detail I learned was the concept of “thematic saturation,” which occurs when additional subjects/interviews start yielding the same themes. It sounds like the equivalent of a sample size/power calculation for qualitative research and helped answer the question on how they determine how many interviews to conduct. Hypothesis-Generating Study Qian et al9 performed a single-institution retrospective study of all retroperitoneal lymph node dissections—144 cases in 10 years, and all with an open technique. This is mostly confirmatory information but a well-detailed cohort and useful basis of comparison for surgeons developing robotic approaches. Hinojosa-Gonzalez et al10 performed a timely analysis of research trends from urology match applicants. A recent trend in the match is the increasing importance of candidates’ research experience—a trend that may increase as USMLE board scores shifting to pass/fail takes away a significant differentiator. The mean/median total publications were 2.44 and 1, respectively. At least 64.2% had at least 1 publication. The authors concluded that publications are valuable to the match selection process, and I would concur with my observation that some of the more competitive/ambitious candidates are finding ways to conduct dedicated research within a medical school curriculum and/or taking a year off for research or a Master’s degree. People, Places, and Things For this month, I highlight the eighth year of the North American Robotic Urology Symposium—a group that is now a new society. The meeting includes live case demonstrations; semi-live lectures; interactions with faculty; hands-on courses; and breakout sessions for young surgeons, allied health, and pediatric robotics. This meeting had over 400 registered, and concurrently, I saw several X postings from the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction and a newer society meeting for benign prostate disease. The large-scale meetings are certainly important to our field and are the gold standard for science and educational events. However, these smaller, subspecialty meetings are clearly popular for attendees and give a lot of opportunity for academic faculty. Figures 1-6 show the pictorial of people, places, and things—including a bonus U2 concert at The Sphere.Figure 1.: People. A, Dan Eun (left) spearheaded a breakout session between the North American Robotic Urology Society and Sunghyun Paick (right) with the Korean Society of Endourology and Robotics. B, Women in robotics: right to left—Kelly Bree, Janet Kukreja, Bogdana Schmidt (JUOP Editor), Alice Yu, and Laura Bukavina. C, Pediatric Robotic Urology—faculty and some of the attendees. D, Allied health faculty put on a hands-on course for robotic bedside assistance.Figure 2.: People—Named Speakers. A, Jim Peabody was the Menon Medal speaker—with an introduction from Mani Menon himself. B, Large Urology Group Practice Association Speaker David Albala (left) with an introduction from James Porter (right). Of note, Dr Albala is the editor of the Journal of Robotic Surgery. His talk focused on the present and future of telemedicine and “telerobotics.” C, JUOP consulting editor Prokar Dasgupta gave the named lecture from the European Robotic Urology Society on the digital age of robotics. JUOP editors know Prokar well from our board meetings when he connects by Zoom at midnight London time.Figure 3.: Places. The eighth year of the North American Robotic Urology Society was at the Bellagio—a centrally located hotel with the famous fountains in the front.Figure 4.: Places. The Sphere is the latest attraction in Las Vegas—a completely spherical building with full dot matrix screens covering inside and out. The moon over the sphere was a nice combination.Figure 5.: Places. The eighth year of the North American Robotic Urology Society coincided with the end of the U2 Achtung Baby resident concert series at The Sphere. From the perspective of a mid-50s surgeon, I have a lot of respect for this band that has been performing and recording since 1976.Figure 6.: Things. With modern hydrogel models, even a hotel conference room can turn into a learning laboratory. This nephrectomy model from the University of Rochester was used by the Allied Health group to train on port placement, bedside assistance, and instrument exchanges.
No takes yet. Share an insight, caveat, or question.
John W. Davis (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: